Senolytics show promise in combating brain aging and COVID-19 neuropathology
Study reveals that senolytics can reduce aging in human brain organoids and mitigate COVID-19 neuropathology, suggesting their potential as a therapeutic strategy against brain aging and coronavirus-related neurological complications.
Jose Luis Calvo Pretreating Bos Nature Aging Coronavirus Disease Covid 19 Central Nervous System Embryonic Stem Cells
Source: news-medical.net